(1 - 29 from 38
)
Milder SMA Types Soon to Enter Trials of AveXis Gene Therapy, AVXS-101
smanewstoday.com
AveXis announces plans for new clinical trials of its gene therapy AVXS-101 in a broad range of SMA patients, including milder SMA types.
AveXis to Present Results from Phase 1 Trial of AVXS-101 in SMA Type...
www.globenewswire.com
-- Key preclinical and clinical data of AVXS-101 in SMA to be presented --
SMA Type 1 Gene Therapy AVXS-101 Focus of AveXis-FDA Meeting to...
smanewstoday.com
AveXis officials will meet with the FDA on May 1 to win approval for its manufacturing process for AVXS-101 gene therapy to treat babies with SMA type 1.
AveXis Gene Therapy for Spinal Muscular Atrophy Pending FDA Approval
themighty.com
... percent survival of the children at 20 months of age,” Sukumar Nagendran, former chief medical officer at AveXis commented in February.
sorted by relevance / date